Stay updated on Nivolumab for Peripheral T-cell Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Peripheral T-cell Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Peripheral T-cell Lymphoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page’s revision tag was updated from v3.5.2 to v3.5.3, indicating an incremental update to the site software. This change is a metadata-level modification and does not affect the study details or visible content.
    Difference
    0.0%
    Check dated 2026-04-30T16:48:48.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. This appears to be a minor patch with no changes to core page content.
    Difference
    0.0%
    Check dated 2026-04-16T10:39:27.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    Added Extranodal nasal NK/T cell lymphoma and CD4+/CD56+ hematodermic neoplasm to the study's listed conditions.
    Difference
    0.1%
    Check dated 2026-04-02T00:11:08.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 from the page.
    Difference
    0.0%
    Check dated 2026-03-25T20:27:23.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T11:37:34.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the previous funding/operation-status notice (Revision: v3.4.1) was removed; these are minor site maintenance updates that do not affect study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:36:10.000Z thumbnail image

Stay in the know with updates to Nivolumab for Peripheral T-cell Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Peripheral T-cell Lymphoma Clinical Trial page.